Cargando…

Galectin-3 as a Marker for Increased Thrombogenicity in COVID-19

Galectin-3 is a beta-galactoside-binding lectin involved in inflammation and lung fibrosis and postulated to enhance thrombosis. In COVID-19, it is considered to be a prognostic marker of severity. The aim of this study was to evaluate whether galectin-3 is associated with thrombogenicity in COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puccini, Marianna, Jakobs, Kai, Reinshagen, Leander, Friebel, Julian, Schencke, Philipp-Alexander, Ghanbari, Emily, Landmesser, Ulf, Haghikia, Arash, Kränkel, Nicolle, Rauch, Ursula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178107/ https://www.ncbi.nlm.nih.gov/pubmed/37175392 http://dx.doi.org/10.3390/ijms24097683

Ejemplares similares

The Role of NETosis and Complement Activation in COVID-19-Associated Coagulopathies
por: Ghanbari, Emily Parissa, et al.
Publicado: (2023)

Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation
por: Jakobs, Kai, et al.
Publicado: (2022)

Micro–RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor
por: Witkowski, Marco, et al.
Publicado: (2016)

Intestinal Barrier Dysfunction and Microbial Translocation in Patients with First-Diagnosed Atrial Fibrillation
por: Blöbaum, Leon, et al.
Publicado: (2023)

Being Overweight or Obese Is Associated with an Increased Platelet Reactivity Despite Dual Antiplatelet Therapy with Aspirin and Clopidogrel
por: Puccini, Marianna, et al.
Publicado: (2022)

Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation
por: Friebel, Julian, et al.
Publicado: (2021)

Adenine Nucleotide Translocase 1 Expression Modulates the Immune Response in Ischemic Hearts
por: Yergöz, Fatih, et al.
Publicado: (2021)

Cytotoxic CD8(+) T Cells Are Involved in the Thrombo-Inflammatory Response during First-Diagnosed Atrial Fibrillation
por: Friebel, Julian, et al.
Publicado: (2022)

Pleiotropic Effects of PCSK9: Focus on Thrombosis and Haemostasis
por: Puccini, Marianna, et al.
Publicado: (2022)

Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes
por: Witkowski, Marco, et al.
Publicado: (2020)

Artificial sweetener sucralose: a possible modulator of autoimmune diseases
por: Kränkel, Nicolle, et al.
Publicado: (2023)

Effects of Apolipoprotein A-I/High-Density Lipoprotein Cholesterol on Atherosclerotic Vascular Disease: Critical Impact of Atherosclerosis Disease Stage and Disease Milieu?
por: Haghikia, Arash, et al.
Publicado: (2018)

Initial therapeutic anticoagulation with rivaroxaban compared to prophylactic therapy with heparins in moderate to severe COVID-19: results of the COVID-PREVENT randomized controlled trial
por: Rauch-Kröhnert, Ursula, et al.
Publicado: (2023)

Age Is Relative—Impact of Donor Age on Induced Pluripotent Stem Cell-Derived Cell Functionality
por: Strässler, Elisabeth Tamara, et al.
Publicado: (2018)

Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes
por: Witkowski, Marco, et al.
Publicado: (2020)

Impact of the Gut Microbiota on Atorvastatin Mediated Effects on Blood Lipids
por: Zimmermann, Friederike, et al.
Publicado: (2020)

Gliflozine – in Zukunft Kardioprotektiva?
por: Rauch-Kröhnert, Ursula, et al.
Publicado: (2021)

Device Thrombogenicity Emulation: An In Silico Predictor of In Vitro and In Vivo Ventricular Assist Device Thrombogenicity
por: Chiu, Wei Che, et al.
Publicado: (2019)

MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes
por: Witkowski, Marco, et al.
Publicado: (2018)

The involvement of multiple thrombogenic and atherogenic markers in premature coronary artery disease
por: Mansur, Antonio P., et al.
Publicado: (2013)

Low-density lipoprotein cholesterol goal attainment in patients with clinical evidence of familial hypercholesterolemia and elevated Lp(a)
por: Schwarz, Andrea, et al.
Publicado: (2022)

Heparanase expression upregulates platelet adhesion activity and thrombogenicity
por: Cui, Hao, et al.
Publicado: (2016)

Rapid Inflammasome Activation Is Attenuated in Post-Myocardial Infarction Monocytes
por: Giral, Hector, et al.
Publicado: (2022)

The Dynamic of Extracellular Vesicles in Patients With Subacute Stroke: Results of the “Biomarkers and Perfusion—Training-Induced Changes After Stroke” (BAPTISe) Study
por: Jödicke, Ruben A., et al.
Publicado: (2021)

Nanomedicine for the reduction of the thrombogenicity of stent coatings
por: Karagkiozaki, Varvara C, et al.
Publicado: (2010)

Extracellular Vesicles and Thrombogenicity in Atrial Fibrillation
por: Berezin, Alexander E., et al.
Publicado: (2022)

Tumor Genetics Are Thrombogenic: The Need for Action
por: Mahé, Isabelle, et al.
Publicado: (2023)

Hyperdense large artery sign in meningitis: A marker of ominous thrombogenic potential of pneumococcus?
por: Mojumder, Deb Kumar, et al.
Publicado: (2014)

You can teach an old dog new tricks: angiopoietin-1 instructs Tie2(pos) myeloid cells to promote neovascularization in ischemic limbs
por: Emanueli, Costanza, et al.
Publicado: (2013)

Tomographic Findings and Thrombogenic Effects of COVID-19
por: Mourão, Rodrigo, et al.
Publicado: (2020)

Targeting thrombogenicity and inflammation in chronic HIV infection
por: O’Brien, Meagan P., et al.
Publicado: (2019)

Thrombogenic and Inflammatory Reactions to Biomaterials in Medical Devices
por: Labarrere, Carlos A., et al.
Publicado: (2020)

Incidence and Predictors of Left Atrial Appendage Thrombus before Catheter Ablation of Thrombogenic Arrhythmias
por: Wegner, Felix K., et al.
Publicado: (2022)

Atrial inflammation and microvascular thrombogenicity are increased in deceased COVID-19 patients()
por: Wu, Linghe, et al.
Publicado: (2023)

Cardiovascular Involvement in Chronic Hepatitis C Virus Infections – Insight from Novel Antiviral Therapies
por: Poller, Wolfgang, et al.
Publicado: (2018)

Thrombogenic Catheter-Associated Superior Vena Cava Syndrome
por: Shaikh, Imran, et al.
Publicado: (2013)

Response to “Tomographic Findings and Thrombogenic Effects of COVID-19”
por: Bao, Cuiping, et al.
Publicado: (2020)

Cryopreservation moderates the thrombogenicity of arterial allografts during storage
por: Hidi, László, et al.
Publicado: (2021)

Assessment of the Anti-Thrombogenic Activity of Polyurethane Starch Composites
por: Cespedes, Jhoan F., et al.
Publicado: (2022)

Diminished Thrombogenic Responses by Deletion of the Podocalyxin Gene in Mouse Megakaryocytes
por: Pericacho, Miguel, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ehkip1f66o5btd2fgo1imp04rq